Regular therapy for human being cytomegalovirus (CMV) depends on inhibition from the viral DNA polymerase. (which makes up about the slope parameter) recognized between 68406-26-8 IC50 mixtures with synergistic, antagonistic, and additive actions. The mix of GCV and foscarnet was somewhat synergistic; solid synergism was discovered when GCV was used in combination with artemisinin-derived monomers… Continue reading Regular therapy for human being cytomegalovirus (CMV) depends on inhibition from